Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Editorial introductions

Editorial introductions URRENT PINION Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS epitope specificities of the serologic response to HIV-1 and the isolation of numerous potent broadly John R. Mascola neutralizing HIV-1 monoclonal antibodies. His laboratory also uses next generation sequencing to study the evolution and maturation of HIV-1 John R. Mascola, MD, has been specific antibody lineages and continues to focus the Director of the Vaccine on understanding antibody-mediated protective Research Center (VRC) of the immune responses against HIV-1 via studies of both National Institutes of Allergy the plasma antibody compartment and the B-cell and Infectious Diseases (NIAID), compartment, in order to inform the design of NIH, USA, since October 2013, improved HIV-1 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and Aids Wolters Kluwer Health

Editorial introductions

Current Opinion in HIV and Aids , Volume 10 (3) – May 1, 2015

Loading next page...
 
/lp/wolters-kluwer-health/editorial-introductions-SjMgy0FpSR

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0000000000000156
Publisher site
See Article on Publisher Site

Abstract

URRENT PINION Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS epitope specificities of the serologic response to HIV-1 and the isolation of numerous potent broadly John R. Mascola neutralizing HIV-1 monoclonal antibodies. His laboratory also uses next generation sequencing to study the evolution and maturation of HIV-1 John R. Mascola, MD, has been specific antibody lineages and continues to focus the Director of the Vaccine on understanding antibody-mediated protective Research Center (VRC) of the immune responses against HIV-1 via studies of both National Institutes of Allergy the plasma antibody compartment and the B-cell and Infectious Diseases (NIAID), compartment, in order to inform the design of NIH, USA, since October 2013, improved HIV-1

Journal

Current Opinion in HIV and AidsWolters Kluwer Health

Published: May 1, 2015

There are no references for this article.